Higher-order CpG-DNA stimulation reveals distinct activation requirements for marginal zone and follicular B cells in lupus mice

被引:19
作者
Brummel, Rachel
Roberts, Tara L.
Stacey, Katryn J.
Lenert, Petar
机构
[1] Univ Iowa, Carver Coll Med, Dept Internal Med, Iowa City, IA 52242 USA
[2] Univ Queensland, Inst Mol Biosci, CRC Chron Inflammatory Dis, Brisbane, Qld, Australia
关键词
autoimmunity; B lymphocytes; CPG; interferons; lupus;
D O I
10.1002/eji.200535734
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Mouse follicular B cells express TLR9 and respond vigorously to stimulation with single-stranded CpG-oligodeoxynucleotides (ODN). Surprisingly, follicular B cells do not respond to direct stimulation with other TLR9 ligands, such as bacterial DNA or class A(D) CpG-ODN capable of forming higher-order structures, unless other cell types are present. Here, we show that priming with interferons or with B cell-activating factor, or simultaneous co-engagement of the B cell receptor for antigen (BCR), can overcome this unresponsiveness. The effect of interferons occurs at the transcriptional level and is mediated through an autocrine/paracrine loop, which is dependent on IRF-1, IL-6 and IL-12 p40. We hypothesize that the lack of bystander activation of follicular B cells with more complex CpG ligands may be an important safety mechanism for avoiding autoimmunity. This will prevent resting B cells from responding to foreign or self-derived hypomethylated double-stranded CpG ligands unless these ligands are either delivered through the B cell receptor or under conditions where B cells are simultaneously co-engaged by activated plasmacytoid dendritic cells or TH1 cells. A corollary is that the heightened responsiveness of lupus B cells to TLR9-induced stimulation cannot be ascribed to unprimed follicular B cells, but is rather mediated by hypersensitive marginal zone B cells.
引用
收藏
页码:1951 / 1962
页数:12
相关论文
共 49 条
  • [31] B lymphocytes as autoantigen-presenting cells in the amplification of autoimmunity
    Roth, R
    Gee, RJ
    Mamula, MJ
    [J]. B LYMPHOCYTES AND AUTOIMMUNITY, 1997, 815 : 88 - 104
  • [32] Toll-like receptor 9 binds single-stranded CpG-DNA in a sequence- and pH-dependent manner
    Rutz, M
    Metzger, J
    Gellert, T
    Luppa, P
    Lipford, GB
    Wagner, H
    Bauer, S
    [J]. EUROPEAN JOURNAL OF IMMUNOLOGY, 2004, 34 (09) : 2541 - 2550
  • [33] SANO H, 1982, J IMMUNOL, V128, P1341
  • [34] Type-I interferon receptor deficiency reduces lupus-like disease in NZB mice
    Santiago-Raber, ML
    Baccala, R
    Haraldsson, KM
    Choubey, D
    Stewart, TA
    Kono, DH
    Theofilopoulos, AN
    [J]. JOURNAL OF EXPERIMENTAL MEDICINE, 2003, 197 (06) : 777 - 788
  • [35] Sparwasser T, 1998, EUR J IMMUNOL, V28, P2045, DOI 10.1002/(SICI)1521-4141(199806)28:06<2045::AID-IMMU2045>3.0.CO
  • [36] 2-8
  • [37] Vaccination with plasmid DNA activates dendritic cells via toll-like receptor 9 (TLR9) but functions in TLR9-deficient mice
    Spies, B
    Hochrein, H
    Vabulas, M
    Huster, K
    Busch, DH
    Schmitz, F
    Heit, A
    Wagner, H
    [J]. JOURNAL OF IMMUNOLOGY, 2003, 171 (11) : 5908 - 5912
  • [38] Stacey KJ, 1996, J IMMUNOL, V157, P2116
  • [39] The molecular basis for the lack of immunostimulatory activity of vertebrate DNA
    Stacey, KJ
    Young, GR
    Clark, F
    Sester, DP
    Roberts, TL
    Naik, S
    Sweet, MJ
    Hume, DA
    [J]. JOURNAL OF IMMUNOLOGY, 2003, 170 (07) : 3614 - 3620
  • [40] Stunz LL, 2002, EUR J IMMUNOL, V32, P1212, DOI 10.1002/1521-4141(200205)32:5<1212::AID-IMMU1212>3.0.CO